Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users

Annals of Neurology

Volumn 40, Issue 3, 1996, Pages 428-439

  Wilson, Julie M ^a   Levey, Allan I ^e   Bergeron, Catherine ^c   Kalasinsky, Kathryn ^f   Ang, Lee ^d   Peretti, Frank ^g   Adams, Vernard I ^h   Smialek, John ^j   Anderson, William R ⁱ   Shannak, Kathleen ^a   Deck, John ^c   Niznik, Hyman B ^b   Kish, Stephen J ^a,b  

^a Hum Neurochemical Pathol Lab   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^g Arkansas State Crime Laboratory   (United States)

^h Office of the Hillsborough County Medical Examiner   (United States)

ⁱ Office of the Medical Examiner of District 9   (United States)

^j UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; COCAINE; DOPAMINE;

ADULT; ARTICLE; BRAIN LEVEL; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ABUSE; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEUROPATHOLOGY; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; SYNAPSE VESICLE;

EID: 9544240448     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410400312     Document Type: Article

References (59)

1. Cardoso FEC, Jankovic J. Cocaine-related movement disorders. Move Disord 1993;8:175-178
2. Daras M, Koppel BS, Atos-Radzion E. Cocaine-induced choreoathetoid movements ("crack dancing"). Neurology 1994;44:751-752
3. Attig E, Amyot R, Botez T. Cocaine induced chronic tics. J Neurol Neurosurg Psychiatry 1994;57:1143-1144
4. Bauer LO. Motoric signs of CNS dysfunction associated with alcohol and cocaine withdrawal. Psychiatry Res 1993;47:69-77
5. Kumor K, Sherer M, Jaffe J. Haloperidol-induced dystonia in cocaine addicts. Lancet 1986;2:1341-1342
6. Hegarty AM, Lipton RB, Merriam AE, Freeman K. Cocaine as a risk factor for acute dystonic reactions. Neurology 1991; 41:1670-1672
7. Satel SL, Swann AC. Extrapyramidal symptoms and cocaine abuse. Am J Psychiatry 1993;150:347 (Letter)
8. Gawin FH, Kleber HD. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch Gen Psychiatry 1986;43:107-113
9. Cottler LB, Shillington AM, Compton WM III, et al. Subjective reports of withdrawal among cocaine users: recommendations for DSM-IV. Drug Alcohol Depend 1993;33:97-104
10. Ross RB, Renyi AL. Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents. Eur J Pharmacol 1967;7:270-277
11. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993;18:247-291
12. DiChiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend 1995;38:95-137
13. Dackis CA, Gold MS. New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Neurobehav Rev 1985;9:469-477
14. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986;9:357-381
15. 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration. J Neurosci 1994;14:2966-2979
16. Hurd YL, Herkenham M. Molecular alterations in the neostriatum of human cocaine addicts. Synapse 1993;13:357-369
17. Hitri A, Casanova MF, Kleinman JE, Wyatt RJ. Fewer dopamine transporter receptors in the prefrontal cortex of cocaine users. Am J Psychiatry 1994;151:1074-1076
18. 3H]WlN 35428 binding sites in human striatum. Brain Res 1993;628:17-25
19. Staley JK, Hearn WL, Ruttenber AJ, et al. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. J Pharmacol Exp Ther 1994; 271:1678-1685
20. Baxter LR, Schwartz JM, Phelps ME, et al. Localization of neurochemical effects of cocaine and other stimulants in the human brain. J Clin Psychiatry 1988;49(suppl):23-26
21. Kaufman MJ, Madras BK. Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's diseased striatum. Synapse 1991;9:43-49
22. Scherman D, Desnos C, Darchen F, et al. Striatal dopamine deficiency in Parkinson's disease: role of aging. Ann Neurol 1989;26:551-557
23. Naudon L, Leroux-Nicollet I, Costentin J. Short-term treatments with haloperidol or bromocriptine do not alter the density of the monoamine vesicular transporter in the substantia nigra. Neurosci Lett 1994;173:1-4
24. Vander Borght TM, Kilbourn MR, Desmond TJ, et al. The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. Eur J Pharmacol 1995;294:577-583
25. Kilbourn MR, Frey KA, Vander Borght T, Sherman PS. Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters. Nucl Med Biol 1996;23:467-471
26. Wilson JM, Carroll ME, Kish SJ. The vesicular monoamine transporter, in contrast to the dopamine transporter, is not regulated following chronic cocaine self-administration. Soc Neurosci Abstr 1995;21:1382 (Abstract)
27. Vander Borght TM, Kilbourn MR, Koeppe RA, et al. In vivo imaging of the brain vesicular monoamine transporter. J Nucl Med 1995;36:2252-2260
28. Riley HA. An atlas of the basal ganglia, brainstem and spinal cord. New York: Hafner, 1960
29. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. N Engl J Med 1988;318:867-880
30. Hörtnagl H, Schlogl E, Sperk G, Hornykiewicz O. The topographical distribution of the monoaminergic innervation in the basal ganglia of the human brain. Prog Brain Res 1983;58: 269-274
31. Wilson JM, Levey AI, Rajput A, et al. Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease. Neurology (In press)
32. 3H]2β-carbomethoxy-3β-(4-fluorophenyl)tropane. Mol Pharmacol 1989;36:518-524
33. Miller GW, Heilman CJ, Perez JT, et al. Altered striatal dopamine transporter immunoreactivity in Parkinson's disease. Soc Neurosci Abstr 1995;21:1251
34. Gu HH, Ahn J, Caplan MJ, et al. Cell-specific sorting of biogenic amine transporters expressed in epithelial cells. J Biol Chem (In press)
35. Kilty JE, Lorang D, Amara SG. Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 1991;254: 528-529
36. Ciliax BJ, Heilman C, Demchyshyn LL, et al. The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 1995;15:1714-1723
37. Weiss F, Markou A, Lorang MT, Koob GF. Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res 1992;593:314-318
38. Parsons LH, Koob GF, Weiss F. Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J Pharmacol Exp Ther 1995; 274:1182-1191
39. Taylor D, Ho BT. Neurochemical effects of cocaine following acute and repeated injection. J Neurosci Res 1977;3:95-101
40. Kalivas PW, Duffy P, DuMars LA, Skinner C. Behavioral and neurochemical effects of acute and daily cocaine administration in rats. J Pharmacol Exp Ther 1988;245:485-492
41. Hadfield MG, Milio C. Cocaine and regional brain monoamines in mice. Pharmacol Biochem Behav 1992;43:395-403
42. Berry J, van Gorp WG, Herzberg DS, et al. Neuropsychological deficits in abstinent cocaine abusers: preliminary findings after two weeks of abstinence. Drug Alcohol Depend 1993;32: 231-237
43. Ardila A, Rosselli M, Strumwasser S. Neuropsychological deficits in chronic cocaine abusers. Intern J Neurosci 1991;57:73-79
44. Beatty WW, Katzung VM, Moreland VJ, Nixon SJ. Neuropsychological performance of recently abstinent alcoholics and cocaine abusers. Drug Alcohol Depend 1995;37:247-253
45. Taylor AE, Saint-Cyr JA. The neuropsychology of Parkinson's disease. Brain Cogn 1995;28:281-296
46. Parsons LH, Smith AD, Justice JB Jr. Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine. Synapse 1991;9:60-65
47. Post RM, Kopanda RT, Black KE. Progressive effects of cocaine on behavior and central amine metabolism in rhesus monkeys: relationship to kindling and psychosis. Biol Psychiatry 1976;11:403-419
48. Farfel GM, Kleven MS, Woolverton WL, et al. Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkeys. Brain Res 1992;578:235-243
49. 123I]β-CIT. J Nucl Med 1995;36:31P (Abstract)
50. Giros B, Wang Y-M, Suter S, et al. Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J Biol Chem 1994;269:15985-15988
51. Vaughan RA. Photoaffinity-labeled ligand binding domains on dopamine transporters identified by peptide mapping. Mol Pharmacol 1995;47:956-964
52. Berger SP, Farrell K, Conant D, et al. Radiation inactivation studies of the dopamine reuptake transporter protein. Mol Pharmacol 1994;46:726-731
53. Milner HE, Béliveau R, Jarvis SM. The in situ size of the dopamine transporter is a tetramer as estimated by radiation inactivation. Biochim Biophys Acta 1994;1190:185-187
54. 3H]WIN 35,428 binding, a marker for dopamine transporter, in embryonic mesencephalic neuronal cultures with striatal membranes of adult rats. J Neurochem 1993;60:469-476
55. Lee FJS, Pristupa ZB, Ciliax BJ, et al. The dopamine transporter carboxyl terminal tail: truncation/substitution mutants selectively confer high affinity dopamine uptake while attenuating recognition of the ligand binding domain. J Biol Chem (In press)
56. Seiden L, Ricuarte GA. Neurotoxicity of methamphetamine and related drugs. In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987: 359-366
57. Schechter MD, Meehan SM. The lethal effects of ethanol and cocaine and their combination in mice: implications for cocaethylene formation. Pharmacol Biochem Behav 1995;52:245-248
58. Li L, Smialek JE. Observations on drug abuse deaths in the state of Maryland. J Forensic Sci 1996;41:106-109
59. Mello NK, Negus SS, Lukas SE, et al. A primate model of polydrug abuse: cocaine and heroin combinations. J Pharmacol Exp Ther 1995;274:1325-1337